By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ultragenyx Pharmaceuticals 

77 Digital Drive
Suite 210
Novato  California  94949  U.S.A.
Phone: 415-884-0223 Fax: 415-884-0562


SEARCH JOBS


Industry
Pharmaceutical






Company News
Ultragenyx Pharmaceuticals (RARE) Announces Intent To File For Conditional Approval In Europe For Sialic Acid Extended-Release Tablets In Hereditary Inclusion Body Myopathy 1/12/2015 7:22:23 AM
Ultragenyx Pharmaceuticals (RARE) Announces License Of Intellectual Property Related To The Treatment Of Huntington's Disease With Triheptanoin 1/8/2015 7:55:26 AM
Ultragenyx Pharmaceuticals (RARE) Initiates New Development Program Studying KRN23 For The Treatment Of Tumor-Induced Osteomalacia 1/6/2015 7:42:09 AM
Ultragenyx Pharmaceuticals (RARE) To Present At The J.P. Morgan Healthcare Conference 1/5/2015 7:26:43 AM
Ultragenyx Pharmaceuticals (RARE) Announces Initiation Of Phase 3 Study Of Recombinant Human Beta-Glucuronidase In Mucopolysaccharidosis Type 7 12/15/2014 7:29:24 AM
Ultragenyx Pharmaceuticals (RARE) To Present At The Oppenheimer Healthcare Conference 12/5/2014 10:58:56 AM
Ultragenyx Pharmaceuticals (RARE) Reports Third Quarter 2014 Financial Results And Corporate Update 11/10/2014 8:03:11 AM
Ultragenyx Pharmaceuticals (RARE) To Present At The Credit Suisse Annual Healthcare Conference 11/4/2014 10:08:43 AM
Ultragenyx Pharmaceuticals (RARE) Granted EU Orphan Drug Designation For KRN23 For The Treatment Of X-Linked Hypophosphatemia 10/30/2014 7:54:56 AM
Ultragenyx Pharmaceuticals (RARE) Granted Orphan Drug Designation For Triheptanoin For The Treatment Of Glucose Transporter Type-1 Deficiency Syndrome 10/27/2014 7:54:46 AM
123456789
//-->